DSP Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1208 Cr | ₹3198 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 28 Dec 2015 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 18% |
Expense Ratio | 2.14 | 1.9 |
Manager | Meeta Shetty | Jay Kothari |
ISIN Code | INF277K016A9 | INF740KA1LD8 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | -8.17% | -7.61% |
6 Month | -10.97% | -7.89% |
1 Year | 9.76% | 12.59% |
3 Year | 19.8% | 21.18% |
5 Year | 22.63% | 24.82% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | -9.97% | -9.68% |
1 Year | -7.58% | -2.74% |
3 Year | 21.18% | 23.58% |
5 Year | 18.31% | 20.17% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 7.82% | 28.82% |
3 Year | 17.79% | 20.72% |
5 Year | 14.55% | 27.72% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 15.471% | 15.136% |
Sharp | 0.874% | 0.954% |
Beta | 0.953% | 0.893% |
Alpha | 0.602% | 2.305% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Meeta Shetty | Jay Kothari |
Total AUM | ₹17847 Cr | ₹0 Cr |
Fund Manage | 5 | 20 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 5.05855 | 18.50057 |
Small Cap | 27.81853 | 49.08227 |
Large Cap | 35.25534 | 18.51288 |
Mid Cap | 31.86756 | 13.9043 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 4.33978 | 1.46973 |
Basic Materials | 2.22397 | - |
Healthcare | 93.43623 | 97.12712 |
Financial Services | - | 1.40317 |
Top Comparisons
Invesco India Largecap Fund - Growth
3Y Returns14.78%
Aditya Birla Sun Life Frontline Equity Fund-Growth
3Y Returns14.91%
INVESCO INDIA FOCUSED FUND - Growth
3Y Returns21.21%
UTI Focused Fund- Regular Plan - Growth Option
3Y Returns15.66%
Kotak Balanced Advantage Fund -Regular Plan - Growth Option
3Y Returns10.96%
Motilal Oswal Balance Advantage Fund (MOFDYNAMIC) - Regular Plan - Growth Option
3Y Returns7.2%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns20.23%
Motilal Oswal Focused 25 Fund (MOF25)- Regular Plan Growth Option
3Y Returns8.84%